Literature DB >> 15696004

Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening.

Kenneth M Boyer1, Ellen Holfels, Nancy Roizen, Charles Swisher, Douglas Mack, Jack Remington, Shawn Withers, Paul Meier, Rima McLeod.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether demographic characteristics, history of exposure to recognized transmission vehicles, or illness that was compatible with acute toxoplasmosis during gestation identified most mothers of infants with congenital toxoplasmosis. STUDY
DESIGN: Mothers of 131 infants and children who were referred to a national study of treatment for congenital toxoplasmosis were characterized demographically and questioned concerning exposure to recognized risk factors or illness.
RESULTS: No broad demographic features identified populations that were at risk. Only 48% of mothers recognized epidemiologic risk factors (direct or indirect exposure to raw/undercooked meat or to cat excrement) or gestational illnesses that were compatible with acute acquired toxoplasmosis during pregnancy.
CONCLUSION: Maternal risk factors or compatible illnesses were recognized in retrospect by fewer than one half of North American mothers of infants with toxoplasmosis. Educational programs might have prevented acquisition of Toxoplasma gondii by those mothers who had clear exposure risks. However, only systematic serologic screening of all pregnant women at prenatal visits or of all newborn infants at birth would prevent or detect a higher proportion of these congenital infections.

Entities:  

Mesh:

Year:  2005        PMID: 15696004     DOI: 10.1016/j.ajog.2004.07.031

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  49 in total

1.  Serological prevalence of Toxoplasma gondii antibodies in pregnant women from Southern Brazil.

Authors:  Rogerio S Vaz; Vanete Thomaz-Soccol; Elaine Sumikawa; Ana Teresa B Guimarães
Journal:  Parasitol Res       Date:  2010-02       Impact factor: 2.289

2.  Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis.

Authors:  O Villard; B Cimon; C L'Ollivier; H Fricker-Hidalgo; N Godineau; S Houze; L Paris; H Pelloux; I Villena; E Candolfi
Journal:  J Clin Microbiol       Date:  2016-10-12       Impact factor: 5.948

3.  Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan.

Authors:  Makiko Sakikawa; Shunichi Noda; Masachi Hanaoka; Hirotoshi Nakayama; Satoshi Hojo; Shigeko Kakinoki; Maki Nakata; Takashi Yasuda; Tsuyomu Ikenoue; Toshiyuki Kojima
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

4.  Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.

Authors:  Sandhya Kortagere; Ernest Mui; Rima McLeod; William J Welsh
Journal:  J Comput Aided Mol Des       Date:  2011-02-26       Impact factor: 3.686

5.  Congenital Toxoplasmosis.

Authors:  James B McAuley
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09       Impact factor: 3.164

6.  Paediatricians' attitudes and practices towards HPV vaccination.

Authors:  Kimiko L Ishibashi; Joy Koopmans; Farr A Curlin; Kenneth A Alexander; Lainie Friedman Ross
Journal:  Acta Paediatr       Date:  2008-07-29       Impact factor: 2.299

7.  Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod
Journal:  Immunome Res       Date:  2010-12-03

8.  Toxoplasmosis during pregnancy: a case report and review of the literature.

Authors:  C Giannoulis; B Zournatzi; A Giomisi; E Diza; I Tzafettas
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

9.  Toxoplasmosis and Toxocariasis: An Assessment of Human Immunodeficiency Virus Comorbidity and Health-Care Costs in Canada.

Authors:  Janna M Schurer; Ellen Rafferty; Michael Schwandt; Wu Zeng; Marwa Farag; Emily J Jenkins
Journal:  Am J Trop Med Hyg       Date:  2016-05-02       Impact factor: 2.345

10.  Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected Infants.

Authors:  Despina Contopoulos-Ioannidis; Kelsey M Wheeler; Raymund Ramirez; Cindy Press; Ernest Mui; Ying Zhou; Christine Van Tubbergen; Sheela Prasad; Yvonne Maldonado; Shawn Withers; Kenneth M Boyer; A Gwendolyn Noble; Peter Rabiah; Charles N Swisher; Peter Heydemann; Kristen Wroblewski; Theodore Karrison; Michael E Grigg; Jose G Montoya; Rima McLeod
Journal:  Clin Infect Dis       Date:  2015-09-24       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.